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cultures, but rather was less. In addition, the percent of total 
extracted protein which needed a reducing agent for solubili -
zation was the same. Thus, the failure of further cell division 
in old cultures is not explainable simply as terminal differen-
t iation. Cells appear to lose their capacity for most cellular 
functions, including t he formation of products characteristic of 
the differentiated cell. The mechanism underlying this change 
is not known , but minoxidil seems to modify it. 
The increase in hair length produced by minoxidil may result 
in part from a prolongation of the anagen phase of the hair 
cycle. This could be viewed as a slowing of senescence of the 
matrix ce lls and a lengthening of the time during which cells 
can divide. Although the aging of cells in culture and the 
conversion of anagen to telogen hairs are different events, they 
both very likely are brought about by some type of metabolic 
signal. A possible mechanism for minoxidil action would be 
preventing release of such a signal or blocking the response to 
it. Furt her studies are necessary to determine which or whether 
eit her of these possibili t ies is correct. 
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Effects of Amino Acid Treatments on 12-0-Tetradecanoylphorbol-13-
acetate-Induced Ornithine Decarboxylase Activity in Mouse Epidermis 
In Vivo and In Vitro* 
JEAN -PIERRE PERCHELLET, PH .D.,t ELIZABETH A. C ONRAD, B.S., AND R. K. BOUTWELL, PH .D. 
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin, U.S. A. 
We have compared the effects of several amino acid 
treatments on the induction of ornithine decarboxylase 
activity and the accumulation of putrescine, spermidine, 
and spermine by 12-0-tetradecanoylphorbol-13-acetate 
(TP A) in mouse epidermis in vivo and in vitro. Incuba-
tion of isolated epidermal cells with mM concentrations 
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Abbreviat ions: 
cyclic AMP: adenosine cycl ic 3':5' -monophosphate 
DMBA: 7,12-dimethylbenz(a]anthracene 
Hepes: N-2 -hydroxyethylpiperazine-N ' -2-ethanesulfonic ac id 
ODC: L-ornithine carboxy-lyase, EC 4.1.1.17 
TPA: 12-0-tetradecanoylphorbol-13-acetate 
of glycine, asparagine, glutamic acid, canavanine, ar-
ginine, and/or lysine inhibited dramatically the induc-
tion of ornithine decarboxylase activity by the tumor 
promoter. These remarkable inhibitory effects were 
concentration-dependent and additive. Arginine and its 
analog, canavanine, inhibited to the same degree TP A-
induced ornithine decarboxylase activity, and poten-
tiated to the same extent the inhibitory effects of glu-
tamic acid, asparagine, and glycine on this enzyme. 
However, the inhibitory effects of arginine and cana-
vanine were not additive. Similar alterations of tumor 
promoter-induced epidermal ornithine decarboxylase 
activity were observed in vivo when 62.5 JLmol of the 
amino acids were injected i.p. 2 h before the topical 
application of 8.5 nmol of TP A to mouse skin. The 
results suggest the possibility that treatments with gly-
cine, asparagine, glutamic acid, and arginine, the amino 
acids that were the most effective in inhibiting the tumor 
promoter-induced accumulation of polyamines in vivo, 
may reduce the tumor-promoting ability of TPA. 
The inhibitory effect of am ino acid imbalance (as opposed to 
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amino acid, protein deficiency) on growth (protein synthesis) 
was discovered very early in nutrit ion research. Since pure 
synt hetic amino acids have been available, t he benefits of excess 
individual amino acids, part icularly arginine, or mixtures of 
several amino acids on the growt h of neoplastic t issue have 
been studied. A survey of the literature reveals t hat diverse 
amino acids supplemented to cul ture medium, administered 
orally in drinking water, fed as a powdered ration , or injected 
i.p. or subcutaneously were able to decrease the carcinogenicity 
of several compounds [1 ,2 ], inhibit the growth rate of different 
tumor cell lines [3,4], and induce t he regression of a variety of 
experimental tumors in animals [5- 12). Therefore, it seems 
t hat the inhibitory process involved lacks specificity. T o the 
best of our knowledge, no one has studied the effects of epider-
mal amino acid imbalances on the induction of skin tumor. 
Unt il recently, there was no clue as to how amino acid 
treatments might inhibit tumor growt h. Because t he faster rate 
of cancer protein synthesis in the growing tumor might upset 
normal protein synthesis, it was speculated t hat t he adminis-
t ration of an extra supply of amino acids would simply provide 
enough raw material to restore the synthesis of normal t issue 
proteins and, t herefore, prevent cachexia and loss of body 
weight and improve the metabolic resistance of t he tumor-
bearing host [11 ,12). An attempt to demonstrate that preven-
tion by arginine glutamate of the carcinogenicity of acetamide 
might be related to the ammonia detoxificat ion fa iled [2). Other 
studies indicated that t he inhibitory effect of arginine on 7,12-
dimethylbenz[aJ anthracene (DMBA)-induced mammary tu-
mors was unlikely to result from alterations in urea cycle 
operation [10] or carcinogen binding to DNA [1] . 
However, the inhibi to ry effects of dietary arginine on growth 
of Ehrlich ascites tumor cells in mice [4] and DMBA-induced 
mammary tumors in rats [9] have been related to reduced 
orni thine decarboxylase (ODC, L-ornit hine carboxy-lyase, EC 
4.1.1.17) activity and polyamine synt hesis. Alt hough these data 
were sketchy, the hypothesis that amino acids might interfe re 
wi th polyamine metabolism is very attractive because t he in-
duction of polyamine biosynt hesis has been suggested to confer 
a selective biologic advantage to tumor t issue and allow fo r 
more rapid growt h [13-15]. Recently, Cho-Chung and collabo-
rators have linked t he inhibitory effects of arginine on growth 
of DMBA-induced mammary carcinoma to the induction of an 
adenosine cyclic 3' :5' -monophosphate (cyclic AMP) -dependent 
system which presumably t ri ggers tumor cell regression [3,8,16-
18]. Since diverse cyclic nucleotide level-raising agents have 
already been shown to inhibit t he early biochemical events . 
linked to skin tumor promotion [19,20], namely the increases 
in polyamine, RNA, protein , and DNA synthesis, it was of 
interest to test the effects of diverse amino acid t reatments on 
12-0-tetradecanoylphorbol-13-acetate (T P A) -stimulated po-
lyamine biosynthesis in mouse epidermis in vivo and in vit ro. 
In the present report, we demonstrate t hat not only arginine 
but other amino acid t reatments as well inhibit the induction 
of ODC activity and the accumulation of polyamines following 
T PA treatment to mouse skin. 
MATERIALS AND METHODS 
Chemicals 
TPA was purchased from Lifesystems Co. (Newton, Massachusetts). 
Dansyl chloride, L-asparagine t-butyl ester-H Cl, L-arginine methyl 
ester-2H C1, L-canavanine, L-glu tamic ac id dimethyl ester-H Cl, L-glu -
tamine t-buty l ester-H Cl, glycine methyl ester-HCl, L-histidine methyl 
ester -2H C1, L- leucine methyl ester-HCl, L- lysine methyl ester-2HC1, L-
ornit hine-H Cl, and crystall ine bovine serum albumin were all obtained 
from Sigma Chemical Co. (St. Louis, Missouri ). P utrescine-2H C1, 
spermidine-3HC1, spermine-4HC1, a nd calf t hymus DNA were from 
Calbiochem-Behring Corp. (La J olla, California). DL-[1-"C]Ornit hine-
H Cl (52.8 mCi/ mmol) , L-[4,5-3H (N)]leucine (55.9 Ci/ mmol) , [' ·'C(U)J 
glycine (113 mCi/ mmol) , and P rotosol were purchased from New 
England Nuclear (Boston, Massachusetts). All other chemicals were 
reagen t grade a nd were obta ined commercially. 
Jncuba.tion Experiments 
The isolated epidermal cells were prepared by t rypsin digestion 
(21] . T he characteristics of t his suspension of isolated epidermal cells 
and t he method of incubation with TPA and other agents have been 
described [20-22]. The total volume of the incubation mixture was 1 
ml; approximately 2 x 106 viable epidermal cells were resuspended in 
0.8 ml of modified Eagle's HeLa cell medium , conta ining 25 mM N-2-
hydroxyethylpiperazine-N ' -2-ethanesulfonic ac id (Hepes) buffer, pH 
7.0, and 10% bovine serum , and t he reagents were added in a total 
volume of 0.2 mi. T he methyl ester or buty l ester L-amino acids and 
the L-amino acid analog were dissolved in the above medium, and pH 
7.0 was restored wit h dilute NaOH before t heir addit ion to t he cell 
suspension. T PA was added to the incubation mixture in 5 .ul of 
dimethyl sul fox ide. 
In Vivo Experiments 
Female Cha rles River CD -1 mice (Wilmington, Massachusetts), 7-9 
weeks old, were housed and ma intained, and their dorsal skins were 
shaved before experimentation as p reviously described [23 ]. T he mice 
received a n i.p. injection of 0.25 ml of freshly prepared 0.9 % NaCI, 
conta ining 25 mM Hepes buffer, pH 7.0, and 250 mM of the methyl 
ester or butyl ester L-amino acids at the appropriate t ime before t he 
topical application to the skin of 8.5 nmol of T PA in 0.2 ml of acetone. 
T he pH of each amino ac id solut ion was always adjusted to pH 7.0 
before injection. 
ODC Activity and P olya.m£n.e Levels 
ODC activity was determined 5 h afte r t he addition of 1 liM TPA to 
t he incubation medium or a fte r t he application of 8.5 nmol of TPA to 
the skin [20- 23]. The incubations were stopped by chilling (21,22]. T he 
mice were killed by cervical dislocation and the epidermis collected by 
a brief heat t reatment [20,23]. The soluble epidermal ext racts contain-
ing ODC activity were prepared from the in tact cells [21] or from t he 
epidermal homogenates from 2 mice [23) as outlined before. ODC 
activity was dete rmined in 0.2- or 0.1 -ml aliquots of the clear super-
natants by measuring t he release of "C0 2 from DL-[1-"C]orni t hine-
HCl essent ially as described previously [21,23]. The assays were carried 
out in duplicate, and all values were corrected against no enzyme or 
boiled enzyme blanks; resul ts were expressed as nmol of C02 released 
in 60 min per 2 X 106 cells or per mg of protein . The levels ofpolyamines 
were determined 6 h afte r TPA treatment [1 9,20,24 ]. T he polyamines 
contained in epidermal prepa rations fro m 4 mice were extracted with 
0.3 N HClO,, dansylated, and separated and quant itated by high-
pressure liquid chromatography essent ially as described earlier 
[19,20]. Triplicate determinations were performed; peak areas were 
integrated and epidermal polyamines were quant itated wi th reference 
to calibration curves prepa red wit h standards of put rescine, spermidine, 
a nd spermine; resul ts in pmol/ p.g DNA are t he mean values of deter-
minations carried out on 2 groups of mice with 4 mice in each group; 
variation was always<± 10%. 
(J H) Leu.cine and f ''C}Glycine Incorporation ,:nto Protein 
T he tota l radioactivity recovered in the epidermis and t he rate of 
incorporation of labeled amino ac ids into epidermal proteins were 
determined at the designated t imes following the i. p. injection of 0.25 
ml of either 250 mM L-leucine methyl ester-HCl wit h 25 pCi of [3H ] 
leucine or 250 mM glycine methyl ester-H Cl wit h 2.5 pCi of [14C]glyc ine 
to different groups of mice. The proteins conta ined in epide rmal 
preparations from 2 mice were recovered wit h 0.5 N HCIO,, extracted 
by a modification [25 ] of the Schmidt- Thannhauser p rocedure [26], 
and hydrolyzed from t he acid-insoluble pellets essent ially as described 
earlier (19]. The radioactivity incorporated into epidermal protein was 
measured in 0.2-ml aliquots of t he 0.5 N NaOH hydrolysates and 
expressed as dpm/ mg of p rotein . Finally, the epidermal residues were 
resuspended in 1 ml of 1M Tris- HCl buffer, pH 6.0, and 0.5-ml aliquots 
were solubilized for radioactivity determination with 2 ml of P rotosol 
for 5 h at 55'C. T he tota l radioactivity recovered from mouse epide rmis 
was t hus estimated as t he sum of t he coun ts associated with t he HClO, 
washes, t he EtOH washes, t he p rotein hydro lysate, a nd the residue. 
The protein concent ration of the various samples was assayed with 
Bio-Rad dye reagent, using crystalline bovine serum albumin as t he 
standard, and the amount of DN A was determined by t he diphenyl-
amine procedure of Burton [27] wi t h calf thymus DNA as t he standard. 
RESULTS 
Studies with Isolated Epidermal Cells 
Incubation of isolated epidermal cells with m M concentra-
tions of glutamic acid and/or glycine resulted in a remarkable 
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inhibit ion of the induction of ODC activity by 1 J.LM TPA. As 
shown in Fig 1, the inhibitory effects of glutamic acid and 
glycine were concent ration-dependent and additive. The inhib-
itory effects of glutamic acid and/or glycine started at concen-
trations as low as 0.025 mM and , in each case, maximum 
alteration ofTPA-induced ODC activity occurred at 2.5-5 mM 
amino acids. The magnitudes of the alterations of basal ODC 
activity by t he same amino acid treatments were much smaller 
in the absence ofTPA (data not shown) . The effects of several 
amino acids (2.5 mM) on TPA-induced ODC activity in isolated 
ep idermal cells have been compared (Table I) . The inhibitory 
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FIG 1. Effects of va rious amino acid concentrations on induction of 
ODC activity by TPA in isolated epidermal cells. Cell suspensions were 
incubated for 5 h with 11LM TPA and t he indicated concentrations of 
the amino acids tested: L-gluta~ic a~id dimethyl ester-HCl , e; glycine 
methyl ester-HCl, 0; L-glutam tc actd dtmethyl ester- HCl + glycine 
methyl este r-HCl, A. The mcubat10n system was as described in 
Materials and Methods. Each point in t he graph is the mean value of 6 
separate determinations from 2 different experiments. Results a re 
expressed as % of the TPA-induced ODC activity in the absence of 
amino ac id (broken line, 2.60 ± 0.21 nmol C0 2/60 min/2 x 106 cells). 
Basal ODC activity (0.15 ± 0.01 nmol C0 2) has been substracted from 
the results. The concent rations are plotted on a logarithmic scale. a, p 
< 0.01, significant ly smaller us TPA. 
TABLE I. Comparison of the effects of diverse amino acid treatments 
on TPA -induced ODC activity in isolated epidermal cells 
ODC activity 
Treatment nmol C02 in % of 60 min/2 x 106 
ce lls TPA 
No addition 0.16 ± 0.01 
TPA 2.49 ± 0.19 100 
+histidine 1.95 ± 0.17" 77 
+glutamine 1.49 ± 0.13 57 
+lysine 1.31 ± 0.10 49 
+arginine 0.98 ± 0.08 35 
+ glu tamic acid 0.77 ± 0.06 26 
+ asparagine 0.63 ± 0.05 20 
+glycine 0.41 ± 0.02 11 
+ arginine + lysine 0.51 ± 0.04 15 
+ glutamic acid + glycine 0.24 ± 0.02 3 
The condit ions of the experiment were ident ical with those in Fig 1. 
Cell suspensions were incubated for 5 h with TPA and the diverse L-
amina ac id methyl ester or butyl ester derivatives tested. The concen-
t rat ions used were: TPA, 1!LM; each amino acid, 2.5 mM . Results, mean 
± SD of 6 separate determinations from 2 different experiments. 
" p < 0.0005, significantly smaller us TPA. 
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effects of glycine, asparagine, glutamic acid, and arginine were 
the most effective, in that order; the inhibition by lysine and 
glutamine was moderate; the effect of histidine was consider-
ably less. None of these treatments altered the time course for 
the induction of ODC activity by TPA [21 ]; maximal stimula-
tion still occurred 5 h after the addition of the tumor promoter 
to the cells (data not shown). The additivity of the treatments 
with inhibitory amino acids is demonstrated by the fact that 
arginine, lysine, and argine + lysine decreased TPA-induced 
ODC activity by 65 %, 51%, and 85%, respectively, whereas 
glutamic acid, glycine, and glutamic acid + glycine inhibited 
the induction of the same enzyme by 74%, 89%, and 97%, 
respectively (Table I) . 
The arginine analog, L-canava nine, competes for the charg-
ing of arginyl-tRNA [28,29] and specifically decreases the in-
corporation of arginine into newly synthesized proteins [29, 
30]. Therefore, increased canavanine incorporation can resul t 
in the production of abnormal proteins and nonfunctional 
enzymes which are more rapidly degraded [29-31]. Since can-
avanine and several other amino acid analogs have been shown 
to alter the synthesis, induction, and breakdown of ODC [31], 
we compared the effects of arginine and canavanine on TPA-
induced ODC activity in the isolated epidermal cell system. 
The resul ts in Table II indicate that arginine and canavanine 
(each at 2.5 mM) inhibited to the same degree the induction of 
ODC activity by TP A and potentiated to the same extent the 
inhibitory effects of glutamic acid, asparagine , and glycine on 
this enzyme. However, the inhibitory effects of arginine and 
canavanine were not additive. These results suggest the possi-
bili ty that the mechanism by which exogenously added arginine 
affects ODC induction may share some similarities with that 
of canavanine. 
Studies with Mouse Epidermis In Vivo 
To determine whether the inhibition of TPA-induced ODC 
activity could be reproduced in mouse epidermis in vivo, we 
first studied the rate of incorporation of i.p. injected ['1H]Ieucine 
and [14C]glyc ine into epidermal proteins (Table Ill, Fig 2). The 
data obtained with the two markers were essent ially the same 
(Fig 2). About 1% of the total radioactivity injected was re-
covered in the epidermis (Table Ill). This resul t suggests that 
the pool of intracellular amino acids readily available for pro-
tei n synthesis in the epidermis may be rapidly a ltered by the 
TABLE II. Comparison of the inhibitory effects of arginine, 
canavanine, and other amino acids on TPA -induced ODC activity in 
isolated epidermal cells 
Treatment 
ODC activity 
nmol C02 in 
60 min/2 X 106 
cells 
No addition 0.14 ± 0.01 
% of 
TPA 
TPA 2.18± 0.17 100 
+arginine 1.29 ± 0.10 56 
+ canava nine 1.22 ± 0.10 53 
+glutamic acid 1.15 ± 0.09 50 
+ asparagine 0.82 ± 0.07 33 
+ glyc ine 0.44 ± 0.02 15 
+arginine + glu tamic ac id 0.71 ± 0.05 28 
+ arginine + asparagine 0.45 ± 0.02 15 
+ arginine + glycine 0.29 ± 0.02 7 
+ canavanine + a rginine 1.25 ± 0.10" 54 
+ canavanine + glu tamic acid 0.66 ± 0.04 25 
+ canavanine + asparagine 0.51 ± 0.04 18 
+ canavanine + glycine 0.27 ± 0.02 6 
The conditions of the experiment were ident ical with those in Table 
I. Cell suspensions were incubated for 5 h wi th TPA, L-canava nine, 
and the diverse L-amina acid methyl ester or butyl ester derivatives 
tested. Concentrations used: TPA, 1!LM ; each amino acid or amino acid 
analog, 2.5 mM. 
"NS, no significance us TPA +arginine and TPA +canavanine. 
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T ABLE III . Distribution of radioactivity recovered from mou.se 
epiderm is after i.p. injection of ["H]leu.cine 
Total % of total radioactivity recovered 
radioactivity 
Time recovered (min) dpm/epidermis HCIO, EtO H Protein Residue (%of washes washes 
radioactivity 
injected) 
2 101,987 67 17 14 2 
(0.18) 
10 382,112 54 16 26 4 
(0.69) 
20 430,077 45 15 34 6 
(0.78) 
60 454,469 38 14 41 7 
(0.82) 
120 484,718 31 13 48 8 
(0.88) 
180 512,245 30 12 49 9 
(0.93) 
240 571,336 33 11 45 11 
(1.04) 
Groups of mice were killed at the indicated t imes following the i.p. 
injection of 25 11Ci of [3H]leucine (approximately 55,386 X 103 dpm ). 
The total dose of amino acid injected into each animal was 62 .5 11mol. 
Radioactivi ty was recovered from mouse epidermis as described in 
M aterials and Method~. Each value represents data from 12 mice in 2 
different experiments. 
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F IG 2. Rate of incorporation of [3H] leucine (e ) and ["C]glyc ine 
(0) in to proteins of mouse epidermis in vivo. Groups of mice were 
kiled at the indicated t imes fo llowing the i.p. injection of 25 11Ci of ["H] 
leucine or 2.5 11Ci of [14C]glycine. The condit ions of the experiment 
were ident ical wi th those in Table III. 
penetration of up to 0.6 J.LmOI of exogenous a mino acid ( 1% of 
t he 62.5 J.Lmol of amino acid injected i.p .) into t he epiderma l 
target cells. The a mount of radioactivity t hat rem a ined cova-
lent ly bound to epiderma l proteins plateaued at about 2 h after 
t he injection of t he am ino acids (F ig 2) a nd represen ted less 
t ha n 50% of t he total radioactivity recovered in t he epiderma l 
fractions (Table III) . Therefore, t hese findings suggest t hat, 
ou t of t he 0.6 J.Lmol of exogenous amino acids t hat have reached 
t he epiderma l cells, up to 0.3 J.Lmo l could be incorporated in to 
t he newly syn t hesized epiderma l proteins after 2 h in our in 
vivo expe rimen ts. Indeed , t he inhibit ion of T P A-induced ODC 
activity by glycine was dependen t on t he t ime of injection 
(T a ble IV) . M axima l inhibi t ion occurred when a single dose of 
62.5 J.Lmol of glycine was injected 2 h before t he top ical appli -
cation of 8 .5 nmol of T P A to t he skin . Two injections of glycine 
at 90 and 120 min before t he application of TPA did not elicit 
a greater inhibi t ion of TPA- induced ODC activity. Effective-
ness was rapidly lost at injection t imes furt her or closer to t he 
t ime of a pplication of TP A, so t hat t he ability of glycine to 
inhibit t he effect of T PA was reduced by 50% when it was 
injected 4 h or 20 min before t he t reatmen t wit h TPA (Table 
IV). 
Therefore, we compa red the effects of diverse amino acids, 
injected i.p. at a dose of 62.5 J.lmol 2 h before TP A t reatment, 
on t he induction of epiderma l ODC activity by t he t umor 
p romoter (Table V). Alt hough lesser , t he inhibitory effects of 
t he amino acids on T P A-induced ODC activity in mouse ep i-
dermis in vivo (Table V) correlated well wit h t he results ob-
tained in vit ro using epiderma l cell suspensions (T able I) . Since 
the induction of polyamine biosynt hesis has been shown to be 
one of t he essent ia l components of mouse skin carcinogenesis 
[32], we compared t he effects of t he amino acids t hat most 
effectively inhibited T P A-induced ODC activity (Tables I, V) 
on t he accumulation of epiderma l polyamines in vivo 6 h 
[19,20,24] fo llowing TPA t reatment (T able VI ). In accord wit h 
the fact t hat i.p . injections of lysine, argin ine, glutamic acid, 
TABLE IV. Effect of the time of injection of glycine on TPA-in.du.ced 
ODC activity in mou.se epidermis in vivo 
Time of 
glycine 
injection 
ODC activity 
before TPA 
treatment (min) 
5 
20 
60 
120 
240 
90 + 120 
Treatment 
Acetone 
TPA 
+ glycine 
+ glycine 
+ glycine 
+glycine 
+glycine 
+ glycine + glycine 
nmol C02 in 
60 min/mg 
protein 
0.18 ± 0.02 
8.05 ± 0.69 
6. 16 ± 0.54 
5.06 ± 0.42 
4.19 ± 0.35 
2.86 ± 0.19 
5.06 ± 0.46 
2.75 ± 0.21" 
%of 
TPA 
100 
76 
62 
51 
34 
62 
33 
Groups of mice were injected i.p. with 62.5 11mol of glycine methyl 
ester-HCl at the indicated t imes before the topical application of 8.5 
nmol of TPA to the skin . Control animals were injected with 0.25 ml 
of 0.9% NaCl, containing 25 mM Hepes buffer, pH 7.0, 5 min before 
the topical application of 0.2 ml of acetone with or without TPA. The 
mice were ki lled 5 h after T PA treatment for enzyme assay. Results 
are the mean± SD of duplicate determinations of enzyme activity from 
6 groups of mice in 2 diffe rent experiments. 
"NS, no significance vs a single injection of glycine at 120 min. 
TABLE V. Co mparison of the effects of diverse amino acid treatments 
on TPA- in.du.ced ODC activity in mou.se epidermis in. vivo 
ODC activity 
Treatment nn10l C02 in % of 60 min/ mg TPA prote in 
Acetone 0.20 ± 0.01 
TPA 9.60 ± 0.80 100 
+ glutamine 7.31 ± 0.59" 76 
+lysine 6.59 ± 0.54 68 
+ arginine 6.25 ± 0.53 64 
+ glutamic acid 4.52 ± 0.40 46 
+ asparagine 3.91 ± 0.29 39 
+ glycine 3.28 ± 0.28 33 
T he condi t ions of the experiment were ident ical with those in Table 
IV. Groups of mice were injected i.p. with 62.5 11mol of the indicated L-
amino acid methyl este r or butyl ester derivatives 2 h before the topical 
application of 8.5 nmol of TPA to the skin . Cont rol animals were 
injected with 0.25 ml of 0.9% NaCl, containing 25 mM Hepes buffer, 
pH 7.0, at the same t ime before the application of 0.2 ml of acetone 
with or without T P A. 
"P < 0.0005, significant ly smaller vs TPA. 
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TABLE VI. Effects of diverse amino acid treatments on TPA-induced polyamine accumulation in mouse epidermis in vivo 
Putrescine Spermidine Spermine 
Treatm ent pmol/ 11g % of pmol/11g % of pmol / 11g % of TPA DNA TPA DNA TPA DNA 
Acetone 44.4 104.1 65.4 
TPA 130.8 100 189. 1 100 68.8 100 
+ lysine 95.1 59 163.1 69 50.7 0 
+ arginine 91.9 55 150.4 54 48.2 0 
+ glutam ic acid 80.8 42 149.7 54 47.9 0 
+asparagine 79.9 41 144.6 48 47.8 0 
+ glycine 68.4 28 131.0 32 40.0 0 
+ arginine+ asparagine 64.1 23 89.6 0 37.6 0 
+ glu tamic ac id+ glycine 55.4 13 81.6 0 36.7 0 
The condi t ions of the experiment were identical with those in Table V. The animals were killed 6 h after TPA treatment for determination 
of t he levels of epidermal polyamines. Results are the mean of triplicate determinations carried out on 2 groups of mice with 4 mice in each 
group; variation was always<± 10%. 
asparagine, and glycine inhibited TPA-induced ODC activity 
in mouse epidermis in vivo by 32%, 36%, 54%, 61 %, and 67%, 
respectively (Table V) , the same amino acid treatments de-
creased the TPA-induced accumulation of putrescine by 41%, 
45 %, 58%, 59 %, and 72%, respectively, and t he much smaller 
accu mulation of spermidine by 31%, 46%, 46%, 52%, and 68%, 
respectively (Table VI). The effects of combined injections were 
additive and Jed to the highest inhibition of TPA-induced 
putrescine accumulat ion, 77- 87% (Table VI), a result t hat is 
compatible with t he inhibitory effect of those same combina-
t ions on the induction of ODC activity in vitro (Tables I, II). 
One interesting feature concerning the inhibitory effects of 
these amino acid treatments on polyamine biosynthesis was 
that the TPA-increased levels of spermidine and the TPA-
insensitive levels of spermine [19,20,24) were both decreased to 
values below the controls by combined injection of arginine + 
asparagine or glutamic acid+ glycine as well as by t he injection 
of several amino acids individually (Table VI) . 
DISCUSSION 
T he present results indicate that diverse amino acid treat-
ments may inhibit t he induction of ODC activity by 1/lM TPA 
in isolated epidermal cells. That t he inhibitory effects of certain 
amino acids could result from their cytotoxicity was ruled out 
for t he fo llowing reasons: (1) Similar data were obtained using 
L-amino acids instead of their methyl ester or butyl ester 
derivatives. However, because the latter were much easier to 
dissolve and appeared more potent in inhibiting the growth of 
DMBA-induced mammary carc inoma in vivo [8], t hey were 
used throughout t his study. (2) Supplementation of up to 20 Ill 
of methyl alcohol or butyl alcohol to 1 ml of cell suspension did 
not alter TPA- induced ODC activity in vitro. (3) Other amino 
ac id derivatives such as L-aspartic acid di -t-butyl ester-HCl, L-
se rine methyl ester-HCl, L-proline methyl ester-HCl, and L-
a lanine methyl ester significant ly enhanced the induction of 
ODC activity by TPA in the same epidermal systems in vivo 
and in vit ro (data not shown) . (4) Various mixtures of several 
inhibitory amino acids, added at a concentration of 12 mM 
each, did not affect cell viability, as verified by t rypan blue 
exclusion test and microscopic examination, nor the ability of 
ODC to be induced once the cell s were was hed and replaced in 
a fresh incubation medium containing TPA. Moreover, the 
value of TPA-induced ODC activity measured in the presence 
of a mixture of stimulatory and inhibitory amino acids was 
identical to the calculated mean of t he values of the different 
TPA-induced ODC activities t hat resu lted from each individual 
am ino ac id treatment (data not shown). 
T he inhibi tory effects of specific amino ac id imbalances 
caused by mM concentrations of exogenous amino acids on t he 
mechanism of induction of ODC activity by TP A in isolated 
epidermal cell s freshly suspended in a complete cul ture medium 
differ from studies demonstrating t hat optimal concentrations 
of specific amino acids are required in a sa lts/glucose medium 
or should be restored to a depleted medium in order to induce 
the full ODC response to diverse growth-promoting age nts (33-
41]. However, it has been reported in some cases that the 
supplementation with 10- 20 mM glutamine and 10 mM glutamic 
acid decreased protein synthesis and strongly inhibited ODC 
activity, respectively [33]. Asparagine and glutamine have also 
been shown to inhibit DNA synthesis in hormone- treated he-
patocytes in primary cul ture, but t hey induced ODC activity 
[ 42]. We found that glycine, asparagine, glutamic acid, argi nine, 
and lysine did inhibit the polyamine nisponse to TPA in mouse 
epidermis in vivo and in vitro. These findings suggest that 
specific amino acid imbalances might interfe re in the ep idermal 
target cells with the mechanism of induction of ODC activity 
by TP A, t hus decreasing the accumulation of polyamines 
caused by the tumor promoter and possibly inhibiting its tumor-
promoting ability. The mechanism of this action remains to be 
determined. 
Since ODC induction requires new protein synt hesis [43-
45], it is important to consider the possibility that the alteration 
of the pool of free cellular amino acids that might result from 
the uptake of unbalanced amounts of amino ac ids into epider-
mal cell s might alter normal peptide and protein synthesis and 
enzyme function. The intracellular concentrations of amino 
acids were not measured during the incubat ion of the isolated 
epidermal cells wit h arginine, glutamic acid, asparagine, and 
glycine, but it seems likely that t he composition of t he int ra-
cellular pool of free amino acids was greatly a ltered by the 
transport of an undete rmined amount of exogenous amino acids 
into the cells. In addition to their role as building blocks of 
protein, the amino acids are precursors of a number of pep t ides, 
many of which have intense biologic activity. Therefore, one 
might ask whether the experimentally increased levels of the 
above amino ac ids might alte r peptide and protein metabolisms, 
presumably by interfering with the transport of other amino 
acids and the specific charging of am inoacyl-tRNAs just as the 
amino acid analogs do [31]. In turn, such phenomena could 
very well induce the repression of enzyme synthesis and/or 
affect t he ul t rastructure, t he activity, and t he breakdown of the 
TPA-induced enzyme. Interestingly, t he inhibition of TPA-
induced epidermal ODC activity is not specific to a certain 
class of amino acids but can be obtained wit h various amino 
acids such as arginine, lysine, asparagine, glutamic acid, glycine, 
and t he analog canavanine. We have shown that the inhibitory 
effects of arginine and canavanine on TPA-induced epidermal 
ODC activity were comparable but not additive (Table II) . In 
addition , the efficacy of the exogenously added amino acids to 
inhibit TPA-induced ODC activity increased in para llel with 
their incorporation into epidermal proteins (Table IV) . Taken 
together, these observations are compatible with t he hypothesis 
that the presence of an altered protein spectrum in the epider-
mis 2 h following amino acid inject ion might affect t he process 
of enzymic induction by TPA. Preliminary experiments indi -
cate that both arginine and canavanine treatments decrease 
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the half-life and increase the rate of heat inactivation of TPA-
induced epidermal ODC.:j: Since canavanine and several other 
amino acid analogs have been reported to alter the synthesis, 
induction , and breakdown of ODC [31] and since the growth-
inhibitory and eventual cancer-chemotherapeutic properties of 
several nonmetabolizable toxic amino acid analogs have been 
described (for review, see [46]) , the possible simila rities be-
tween the mechanisms by which exogenously added amino acids 
and amino acid analogs inhibit ODC induction remain to be 
identified. 
Derivatization of epidermal polyamines was accomplished 
with an 8 mg/ml solut ion of dansyl chloride overnight [19]. 
Since extraction/ recovery experiments with standards of pu-
t rescine, spermidine, and spermine gave similar values in the 
presence and absence of J.Lmol amounts of each amino acid 
tested, it is suggested t hat there was enough dansyl chloride 
around to fully derivatize the epidermal polyamines and that 
the inhibition of TPA-induced polyamine accumulat ion by 
glycine, asparagine, glutamic acid, arginine, and lysine (Table 
VI) was not the result of a competit ion with the polyamines for 
the dansyl chloride. Moreover, the inhibitory effect of arginine 
on TPA-induced ODC activity in vivo and in vitro is consistent 
with the observation that the level of epidermal arginase, which 
catalyzes the hydrolysis of a rginine to ornithine and urea, is 
not a limit ing factor for the stimulat ion of polyamine biosyn-
t hesis by TPA [47]. 
Current and future investigations are aimed at elucidating 
the mechanisms by which arginine and the other amino acids 
and amino acid analogs t hat inhibited the effect of TP A on the 
polyamine biosynthetic pathway in this study would influence 
the promoting ability of TPA. Recently, it has been postulated 
that arginine would enhance t he formation and the nuclear 
translocation of the cyclic AMP receptor complex which pre-
sumab ly triggers tumor cell regression [8,16- 18). Moreover, L -
arginine has also been identified as an endogenous activator 
for soluble guanylate cyclase from neuroblastoma cells [48]. 
Since cyclic AMP and guanosine cyclic 3':5' -monophosphate 
(cyclic GMP) treatments as well as several enhancers of the 
cyclic nucleotide response to TP A have been shown to inhibit 
t he biochemical steps linked to skin tumor promotion [19,20], 
it would be very inte resting to determine t he effects of arginine 
and lysine as well as glycine, asparagine, and glutamic acid on 
the metabolism of the cyclic nucleotides in TPA-treated mouse 
epidermis. 
:j: Perchellet JP, Posey T , Owen M: Manuscript in preparation. 
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Anthralin Inhibition of Mouse Epidermal Arachidonic Acid 
Lipoxygenase In Vitro* 
C HARLES J. BEDORD, PH.D ., JOHN M. YOUNG, PH.D., AND BONNIE M. WAGNER, B.S. 
Department of Shin Biology, Syntex Research, Palo Alto, California, U.S.A . 
Epidermal strips, free of sebaceous gland and hair 
follicle contamination, were prepared from mouse tail 
skin. Epidermal homogenates synthesized prostaglan-
dins a nd 12-hydroxy-5,8,10,14-eicosatetraenoic acid 
(12-HETE) from exogenously added [1- 14C]arachidonic 
acid. The effects of pH, assay time, substrate concentra-
t ion, a nd several selective inhibitors upon the lipoxy-
genase and cyclooxygenase pathways were determined. 
Ultracentrifugation of the crude homogenate at 105,000 
g sedimented both activities, and pellet 12-HETE syn-
thesis increased 2-fold r elative to the crude homogenate. 
Recombination of the 105,000 g pellet and supernatant 
gave y ields of prostaglandins and 12-HETE essentially 
equivale nt to that of crude homogenate. 
Manuscript received April 11, 1983; accepted for publication 
Ju ly 27, 1983. 
*Part of this work was presented at the Western Region, Society 
for Investigative Dermatology Meetings, Februa ry 1982, Carmel, Cali -
fornia. 
Reprint requests to: Cha rles J . Bedord, P h.D ., Department of Skin 
Biology, Syntex Research, 3401 Hillview Avenue, Palo Alto, California 
94304 . 
Abbreviations: 
CDNQ: 6-chloro-2,3-dihydroxy-1,4- napht hoquinone 
DHAQ: 1,8-dihydroxy-9,10-ant hraquinone 
EGTA: ethyleneglycol-bis-{#-am inoethyl ether) -N ,N '- tetraacetic 
ac id 
GLC- MS: gas liquid chromatography- mass spectrometry 
HETE: hydroxyeicosatetrae noic ac id 
IC: inhibitory concentration 
NDGA: nordihydroguaiaretic acid 
PG: prostaglandin 
TLC: t hin -layer chromatography 
When tested in homogenate with 4.5 JLM arachidonic 
acid, anthralin specifically inhibited 12-HETE produc-
tion with IC5 0 of 50.0 JLM; no significant effect against 
cyclooxygenase was observed over the dose range of 2-
200 JLM. 1,8-Dihydroxy-9,10-anthraquinone (DHAQ) 
also specifically inhibited 12-HETE synthesis, but the 
dose response curve was flatter and maximum inhibition 
was only 55% at 200 JLM. 
6 - Chloro - 2,3 - dihydroxy - 1,4 - naphthoquinone 
(CDNQ), an agent with topical antipsoriatic activity, 
also inhibited 12-HETE synthesis with an IC50 of 25 JLM, 
but simultaneously stimulated prostaglandin produc-
tion, up to 2.5-fold at 200 JLM. 
When tested with washed human platelets, anthralin 
again specifically inhibited 12-HETE production with 
an IC5 0 of 10 JLM, while DHAQ inhibited lipoxygenase 
activity by only 40 % at 25 JLM. When tested in platelets, 
CDNQ gave 33% inhibition of 12-HETE production at 
200 JLM, although prostaglandin synthesis was stimu-
la ted over the range pf 25-200 JLM. It is proposed that 
certain antipsoriatic agents may exert their action 
through modulation of arachidonic acid metabolism. 
Epidermis possesses enzymes capable of metabolizing arach-
idonic acid into cyclooxygenase (PGF~ ... PGD2 , PGE2 ) and 
lipoxygenase (12-HETE) products [1 ,2]. While oxygenated ar-
achidonic acid products are clearly involved in inflammatory 
processes [3], their involvement in t issue homeostasis has not 
been established. In many inflammatory skin condit ions, re-
leased arachidonic acid is substantially metabolized via the 
cyclooxygenase pathway, resulting in dramatic elevations in 
prostaglandins (4,5]. Although lipoxygenase products were not 
